Skip to main content

Nasdaq IPOs

Leading cybersecurity brand McAfee sets terms for $759 million IPO

5 years 11 months ago
McAfee, a leading provider of antivirus and endpoint security software, announced terms for its IPO on Tuesday. The San Jose, CA-based company plans to raise $759 million by offering 37 million shares (21% secondary/synthetic) at a price range of $19 to $22. At the midpoint of t
Renaissance Capital

Leading cybersecurity brand McAfee sets terms for $759 million IPO

5 years 11 months ago
McAfee, a leading provider of antivirus and endpoint security software, announced terms for its IPO on Tuesday. The San Jose, CA-based company plans to raise $759 million by offering 37 million shares (21% secondary/synthetic) at a price range of $19 to $22. At the midpoint of th
Renaissance Capital

Leading cybersecurity brand McAfee sets terms for $759 million IPO

5 years 11 months ago
McAfee, a leading provider of antivirus and endpoint security software, announced terms for its IPO on Tuesday. The San Jose, CA-based company plans to raise $759 million by offering 37 million shares (16% insider) at a price range of $19 to $22. At the midpoint of the proposed r
Renaissance Capital

The 3Q20 IPO Market's Law Firm Leaderboard

5 years 11 months ago
The 3Q20 was a record-breaking quarter for IPO activity, with 81 IPOs raising $28.5 billion. Soaring peer multiples and IPO enthusiasm caused activity to increase significantly from the 3Q19, when 39 IPOs raised $10.8 billion. Healthcare was the most active sector, as larger heal
Renaissance Capital

The 3Q20 IPO Market's Law Firm Leaderboard

5 years 11 months ago
The 3Q20 was a record-breaking quarter for IPO activity, with 81 IPOs raising $28.5 billion. Soaring peer multiples and IPO enthusiasm caused activity to increase significantly from the 3Q19, when 39 IPOs raised $10.8 billion. Healthcare was the most active sector, as larger heal
Renaissance Capital

US IPO Weekly Recap: Healthcare dominates a 7 IPO week

5 years 11 months ago
Seven IPOs and 10 SPACs went public this past week. The IPO pipeline remained active, with 11 IPOs and 22 SPACs submitting initial filings. Phase 2 biotech Kronos Bio (KRON) priced above the range to raise $250 million at a $1.1 billion market cap. The biotech is developing ther
Renaissance Capital
Checked
21 minutes 11 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed